Angiodynamics Inc (ANGO)

Mar 31, 2025, 8:00 AM EDT - 1 day ago

AngioDynamics to Host Virtual Cardiovascular Investor Event

Mar 19, 2025, 8:00 AM EDT - 13 days ago

AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event

Mar 10, 2025, 4:30 PM EDT - 22 days ago

AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference

Jan 30, 2025, 7:30 AM EST - 2 months ago

AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia

Jan 16, 2025, 5:07 AM EST - 2 months ago

AngioDynamics: Improving Financial Performance And Good Clinical Data Reinvigorate The Shares

Jan 13, 2025, 8:00 AM EST - 2 months ago

AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI

Jan 8, 2025, 5:15 PM EST - 2 months ago

AngioDynamics: A Surgical Approach To Market Growth

Jan 8, 2025, 11:00 AM EST - 2 months ago

AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript

Jan 8, 2025, 6:30 AM EST - 2 months ago

AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results

Jan 6, 2025, 9:26 AM EST - 3 months ago

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

Jan 6, 2025, 9:25 AM EST - 3 months ago

AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System

Dec 19, 2024, 5:00 PM EST - 3 months ago

AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event

Dec 9, 2024, 6:00 AM EST - 4 months ago

AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation

Oct 23, 2024, 8:00 AM EDT - 5 months ago

AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System

Oct 21, 2024, 8:00 AM EDT - 5 months ago

AngioDynamics Announces American Medical Association's CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver

Oct 3, 2024, 10:29 AM EDT - 6 months ago

AngioDynamics, Inc. (ANGO) Q1 2025 Earnings Call Transcript

Oct 3, 2024, 10:02 AM EDT - 6 months ago

AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday

LEVI NGVT

Oct 3, 2024, 6:30 AM EDT - 6 months ago

AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results

Oct 3, 2024, 3:37 AM EDT - 6 months ago

Top Wall Street Forecasters Revamp AngioDynamics Price Expectations Ahead Of Q1 Earnings

Sep 19, 2024, 4:40 PM EDT - 6 months ago

AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes

Sep 19, 2024, 8:00 AM EDT - 6 months ago

AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024

Sep 3, 2024, 8:30 AM EDT - 7 months ago

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

Jul 29, 2024, 4:15 PM EDT - 8 months ago

AngioDynamics to Participate in Upcoming Investor Conferences

Jul 17, 2024, 3:16 PM EDT - 9 months ago

AngioDynamics: Lumpy Progress Is Still Progress

Jul 16, 2024, 1:51 PM EDT - 9 months ago

Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance

Jul 16, 2024, 10:35 AM EDT - 9 months ago

AngioDynamics (ANGO) Q4 2024 Earnings Call Transcript

Jul 16, 2024, 6:30 AM EDT - 9 months ago

AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results

Jul 8, 2024, 4:30 PM EDT - 9 months ago

AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024

May 21, 2024, 5:30 PM EDT - 11 months ago

AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System

May 6, 2024, 4:45 PM EDT - 11 months ago

AngioDynamics' APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions

Apr 9, 2024, 4:49 PM EDT - 1 year ago

A Leaner AngioDynamics Is A High-Risk Execution-Driven Story

Apr 4, 2024, 11:11 AM EDT - 1 year ago

AngioDynamics (ANGO) Q3 2024 Earnings Call Transcript

Apr 4, 2024, 7:00 AM EDT - 1 year ago

AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture

Apr 4, 2024, 6:45 AM EDT - 1 year ago

AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE

Apr 1, 2024, 5:26 PM EDT - 1 year ago

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

Mar 19, 2024, 4:01 PM EDT - 1 year ago

AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024

Mar 6, 2024, 4:01 PM EST - 1 year ago

AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference

Feb 15, 2024, 4:05 PM EST - 1 year ago

AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million

Jan 23, 2024, 8:00 AM EST - 1 year ago

AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease

Jan 5, 2024, 10:26 AM EST - 1 year ago

AngioDynamics, Inc. (ANGO) Q2 2024 Earnings Call Transcript

Jan 5, 2024, 8:13 AM EST - 1 year ago

AngioDynamics stock dives after sales miss, lowered full-year outlook

Jan 5, 2024, 7:00 AM EST - 1 year ago

AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance

Dec 7, 2023, 4:01 PM EST - 1 year ago

AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024

Dec 7, 2023, 8:00 AM EST - 1 year ago

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

Oct 4, 2023, 10:35 AM EDT - 1 year ago

AngioDynamics, Inc. (ANGO) Q1 2024 Earnings Call Transcript

Oct 4, 2023, 7:00 AM EDT - 1 year ago

AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance

Sep 17, 2023, 3:52 AM EDT - 1 year ago

AngioDynamics: Enormous Effort Required In Fiscal '24 To Reverse The Equity Picture

Sep 12, 2023, 4:01 PM EDT - 1 year ago

AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023

Aug 15, 2023, 4:01 PM EDT - 1 year ago

AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation

Aug 3, 2023, 8:00 AM EDT - 1 year ago

AngioDynamics Completes Enrollment for PRESERVE Clinical Study